All Research Papers Published In European Urology Oncology | R Discovery

Cancel

Export

Sort by: Relevance

New
Research Article
10.1016/j.euo.2025.11.016

Benchmarking Large Language Models Against Multidisciplinary Tumor Boards in Urological Oncology: Results from the Blinded, Prospective CONCORDIA Study.

Dec 10, 2025
European urology oncology
Emily Rinderknecht + 18 more

New
Research Article
10.1016/j.euo.2025.11.011

Prostate-specific Membrane Antigen Positron Emission Tomography Versus Conventional Imaging for Preoperative Staging High-risk Prostate Cancer Patients Undergoing Surgery for cN0M0 Disease: An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study.

Dec 5, 2025
European urology oncology
Lorenzo Bianchi + 33 more

New
Research Article
10.1016/j.euo.2025.11.012

Reply to Constance Huck, Paul Sargos, and Alberto Bossi's Letter to the Editor re: Markus Graefen, Fabian Falkenbach, Tobias Maurer, et al. Best Systemic Therapy With or Without Radical Prostatectomy in the Management of Men With Oligometastatic Prostate Cancer: The RAMPP Randomised Controlled Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.09.4144.

Dec 3, 2025
European urology oncology
Fabian Falkenbach + 2 more

New
Front Matter
10.1016/j.euo.2025.11.008

Penile Cancer Survivorship: Research Gaps in Psychosocial Health and Sexual Quality of Life.

Dec 3, 2025
European urology oncology
Cameron J Britton + 6 more

New
Front Matter
10.1016/j.euo.2025.11.013

Assessment of Pathologic Response in Kidney Cancer: Back to the Microscope for Now.

Dec 3, 2025
European urology oncology
Axel Bex + 1 more

New
Research Article
10.1016/j.euo.2025.11.015

Germline DNA Repair and Immune-metabolic Alterations Suggest a Potentially Distinct Form of Early-onset Prostate Cancer in Men of African Descent.

Dec 1, 2025
European urology oncology
Jean-Samuel Loger + 14 more

New
Front Matter
10.1016/j.euo.2025.11.001

Circulating Tumor DNA in Muscle-invasive Bladder Cancer: Promise, Pitfalls, and Path Forward.

Nov 18, 2025
European urology oncology
Clara Cerrato + 2 more

Research Article
10.1016/j.euo.2025.09.010

Patient-reported Outcomes for Men with Metastatic Castration-resistant Prostate Cancer Who Received Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Phase 3 PROpel Study.

Nov 17, 2025
European urology oncology
Andrew J Armstrong + 17 more

Research Article
10.1016/j.euo.2025.10.013

Neoadjuvant Antiandrogen Therapy With or Without MEK or SRC Inhibition for Unfavorable-risk Prostate Cancer: A Phase 2 Randomized Clinical Trial.

Nov 8, 2025
European urology oncology
Raag Agrawal + 10 more

Research Article
10.1016/j.euo.2025.10.009

Radiotherapy plus Long-term Adjuvant Androgen Deprivation with a Luteinizing Hormone-releasing Hormone Antagonist Versus Agonist in Patients with Very High-risk Localized or Locally Advanced Prostate Cancer: The EORTC GUCG-1414 Phase 3 Randomized Trial.

Nov 7, 2025
European urology oncology
Thomas Zilli + 16 more

1

2

3

4

5

6